Eye drop trial targets microscopic eyelash mites
NCT ID NCT05454956
Summary
This study tested the safety and effectiveness of an eye drop called TP-03 for treating a common eyelid condition linked to tiny mites. It compared using the drops twice a day versus three times a day in 39 adults who had the condition. The goal was to see which schedule worked better to improve eyelid health and reduce symptoms like redness and dry eye.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEIBOMIAN GLAND DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CORE Inc.
Shelby, North Carolina, 28150, United States
-
Medical Optometry America
New Freedom, Pennsylvania, 17349, United States
-
Mitchell C. Shultz, MD
Northridge, California, 91325, United States
-
Oculus Research
Cary, North Carolina, 27513, United States
-
Silverstein Eye Center
Kansas City, Missouri, 64133, United States
Conditions
Explore the condition pages connected to this study.